Veeva Systems ROA 2012-2025 | VEEV
Current and historical return on assets (ROA) values for Veeva Systems (VEEV) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Veeva Systems ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-04-30 | $0.78B | $7.77B | 11.20% |
| 2025-01-31 | $0.72B | $7.34B | 10.87% |
| 2024-10-31 | $0.67B | $6.45B | 10.71% |
| 2024-07-31 | $0.62B | $6.33B | 10.40% |
| 2024-04-30 | $0.56B | $6.19B | 9.86% |
| 2024-01-31 | $0.53B | $5.91B | 9.84% |
| 2023-10-31 | $0.57B | $5.23B | 11.20% |
| 2023-07-31 | $0.54B | $5.23B | 11.25% |
| 2023-04-30 | $0.52B | $5.02B | 11.47% |
| 2023-01-31 | $0.49B | $4.80B | 11.41% |
| 2022-10-31 | $0.40B | $4.18B | 9.82% |
| 2022-07-31 | $0.39B | $4.12B | 10.29% |
| 2022-04-30 | $0.41B | $4.01B | 11.33% |
| 2022-01-31 | $0.43B | $3.82B | 12.45% |
| 2021-10-31 | $0.43B | $3.37B | 13.37% |
| 2021-07-31 | $0.43B | $3.35B | 13.93% |
| 2021-04-30 | $0.41B | $3.22B | 14.43% |
| 2021-01-31 | $0.38B | $3.05B | 14.44% |
| 2020-10-31 | $0.34B | $2.58B | 14.07% |
| 2020-07-31 | $0.33B | $2.52B | 14.47% |
| 2020-04-30 | $0.31B | $2.41B | 14.89% |
| 2020-01-31 | $0.30B | $2.27B | 15.37% |
| 2019-10-31 | $0.31B | $1.90B | 16.97% |
| 2019-07-31 | $0.29B | $1.86B | 17.17% |
| 2019-04-30 | $0.26B | $1.78B | 16.67% |
| 2019-01-31 | $0.23B | $1.65B | 15.97% |
| 2018-10-31 | $0.20B | $1.40B | 14.99% |
| 2018-07-31 | $0.17B | $1.37B | 13.71% |
| 2018-04-30 | $0.16B | $1.32B | 13.74% |
| 2018-01-31 | $0.15B | $1.23B | 14.11% |
| 2017-10-31 | $0.14B | $1.05B | 14.12% |
| 2017-07-31 | $0.13B | $1.04B | 13.70% |
| 2017-04-30 | $0.10B | $1.00B | 11.70% |
| 2017-01-31 | $0.08B | $0.92B | 9.62% |
| 2016-10-31 | $0.07B | $0.79B | 8.70% |
| 2016-07-31 | $0.05B | $0.79B | 7.53% |
| 2016-04-30 | $0.05B | $0.75B | 8.07% |
| 2016-01-31 | $0.05B | $0.71B | 8.67% |
| 2015-10-31 | $0.05B | $0.63B | 8.41% |
| 2015-07-31 | $0.05B | $0.59B | 8.91% |
| 2015-04-30 | $0.05B | $0.57B | 8.88% |
| 2015-01-31 | $0.04B | $0.55B | 8.26% |
| 2014-10-31 | $0.02B | $0.49B | 5.45% |
| 2014-07-31 | $0.02B | $0.46B | 3.97% |
| 2014-04-30 | $0.01B | $0.44B | 4.17% |
| 2014-01-31 | $0.01B | $0.37B | 5.59% |
| 2013-07-31 | $0.02B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $46.128B | $2.747B |
| Veeva Systems Inc. offers cloud-based software applications and data solutions for the life sciences industry. The company's product portfolio includes Veeva CRM (customer relationship management), Veeva Vault (content and information management), Veeva Network (customer master and product data management) and Veeva data services (Veeva OpenData and Veeva KOL data). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hims & Hers Health (HIMS) | United States | $11.646B | 121.00 |
| Doximity (DOCS) | United States | $11.561B | 53.52 |
| Tempus AI (TEM) | United States | $10.010B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.435B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.842B | 60.03 |
| Hinge Health (HNGE) | United States | $3.739B | 0.00 |
| Privia Health (PRVA) | United States | $2.547B | 174.08 |
| Enovis (ENOV) | United States | $1.826B | 10.18 |
| Phreesia (PHR) | United States | $1.642B | 0.00 |
| Schrodinger (SDGR) | United States | $1.551B | 0.00 |
| 10x Genomics (TXG) | United States | $1.535B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.527B | 0.00 |
| Azenta (AZTA) | United States | $1.475B | 68.57 |
| Evolent Health (EVH) | United States | $1.334B | 113.60 |
| Omnicell (OMCL) | United States | $1.291B | 22.78 |
| Claritev (CTEV) | United States | $0.763B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.582B | 0.00 |
| Veradigm (MDRX) | United States | $0.547B | 0.00 |
| Standard BioTools (LAB) | United States | $0.475B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.450B | 0.00 |
| Talkspace (TALK) | United States | $0.430B | 128.50 |
| Outset Medical (OM) | United States | $0.333B | 0.00 |
| TruBridge (TBRG) | United States | $0.329B | 731.00 |
| Health Catalyst (HCAT) | United States | $0.269B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.267B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.231B | 0.00 |
| CapsoVision (CV) | United States | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.149B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.139B | 0.00 |
| American Well (AMWL) | United States | $0.126B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.122B | 0.00 |
| Pulmonx (LUNG) | United States | $0.108B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.104B | 0.00 |
| CareCloud (CCLD) | United States | $0.098B | 3.73 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.091B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.081B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
| HeartBeam (BEAT) | United States | $0.042B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |